Rochester, NY 9/1/2009 10:15:22 AM
Myriad Genetics Inc. MYGN, Market Trade Down 0.29% at the end of the trade sesssion
Myriad Genetics Inc.
Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present an overview of the Company at The Morgan Stanley Global Healthcare Conference, at 10:20 a.m. Eastern on September 14, 2009, at the Grand Hyatt Hotel in New York City.
http://stockeinstein.com/ offers free daily stock alerts on companies ready to run. Scroll to BOTTOM of this page for free stock alerts, or visit our site.
Last Trade: 30.57
Day's Range: 29.82 - 30.58
52wk Range: 24.28 - 47.08
Change: Down 0.09 (0.29%)
Volume: 1,490,358
Avg Vol (3m): 2,164,230
About Myriad Genetics, Inc.
Myriad Genetics, Inc. is a healthcare company focused on the development and marketing of molecular diagnostic products. The Company is focused on providing physicians with information that guide the healthcare management of their patients to prevent disease, delay the onset of disease, or catch the disease at an earlier stage when it is treatable. As of June 30, 2009, the Company launched seven commercial molecular diagnostic products, including four predictive medicine and three personalized medicine products. It markets the products through its 300-person sales force in the United States. On June 30, 2009, the Company spun-off its research and drug development businesses for the treatment of cancers and other diseases into its wholly owned subsidiary, Myriad Pharmaceuticals, Inc. (MPI).
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.
